The Role of the Noradrenergic System in Eating Disorders: A Systematic Review
Open Access
- 14 October 2021
- journal article
- review article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 22 (20) , 11086
Abstract
Noradrenaline (NE) is a catecholamine acting as both a neurotransmitter and a hormone, with relevant effects in modulating feeding behavior and satiety. Several studies have assessed the relationship between the noradrenergic system and Eating Disorders (EDs). This systematic review aims to report the existing literature on the role of the noradrenergic system in the development and treatment of EDs. A total of 35 studies were included. Preclinical studies demonstrated an involvement of the noradrenergic pathways in binge-like behaviors. Genetic studies on polymorphisms in genes coding for NE transporters and regulating enzymes have shown conflicting evidence. Clinical studies have reported non-unanimous evidence for the existence of absolute alterations in plasma NE values in patients with Anorexia Nervosa (AN) and Bulimia Nervosa (BN). Pharmacological studies have documented the efficacy of noradrenaline-modulating therapies in the treatment of BN and Binge Eating Disorder (BED). Insufficient evidence was found concerning the noradrenergic-mediated genetics of BED and BN, and psychopharmacological treatments targeting the noradrenergic system in AN. According to these data, further studies are required to expand the existing knowledge on the noradrenergic system as a potential target for treatments of EDs.Keywords
This publication has 80 references indexed in Scilit:
- The Role of “Mixed” Orexigenic and Anorexigenic Signals and Autoantibodies Reacting with Appetite-Regulating Neuropeptides and Peptides of the Adipose Tissue-Gut-Brain Axis: Relevance to Food Intake and Nutritional Status in Patients with Anorexia Nervosa and Bulimia NervosaInternational Journal of Endocrinology, 2013
- Anorexia nervosa – A noradrenergic dysregulation hypothesisMedical Hypotheses, 2012
- CCK Stimulation of GLP-1 Neurons Involves α1-Adrenoceptor–Mediated Increase in Glutamatergic Synaptic InputsDiabetes, 2011
- Duloxetine in the treatment of binge eating disorder with depressive disorders: A placebo‐controlled trialInternational Journal of Eating Disorders, 2011
- Anorexia nervosa versus hyperinsulinism: therapeutic effects of neuropharmacological manipulationTherapeutics and Clinical Risk Management, 2011
- Chronic Stress, Combined with a High‐Fat/High‐Sugar Diet, Shifts Sympathetic Signaling toward Neuropeptide Y and Leads to Obesity and the Metabolic SyndromeAnnals of the New York Academy of Sciences, 2008
- Neurobiology of anorexia and bulimia nervosaPhysiology & Behavior, 2008
- Peripheral ghrelin transmits orexigenic signals through the noradrenergic pathway from the hindbrain to the hypothalamusCell Metabolism, 2006
- Basal and exercise‐induced sympathetic nervous activity and lipolysis in adipose tissue of patients with anorexia nervosaEuropean Journal of Clinical Investigation, 2004
- Modulation of feeding by hypothalamic paraventricular nucleus α1- and α2-adrenergic receptorsLife Sciences, 1993